Research Article
Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease
Table 2
Hematological changes following antiviral therapy.
| Variable | Baseline | End of treatment | Change | value |
| Platelet count | | | | | | | | | ≤0.001 | Median (IQR) | 119 (100.30 : 134) | 145 (116.50 : 186) | 26 (16.20 : 52) | WBCs | | | | | | | | | ≤0.032 | Median (IQR) | 5.4 (4.3 : 6.55) | 5.75 (4.5 : 7.7) | 0.35 (0.2 : 1.15) | Hemoglobin | | | | | | | | | ≤0.001 | Median (IQR) | 13.95 (12.85 : 15.25) | 12.60 (11.70 : 13.75) | -1.35 (1.15 : 1.5) |
|
|
SD: standard deviation; IQR: interquartile range; WBCs: white blood cells.
|